NTI 3.28% 5.9¢ neurotech international limited

Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint, page-26

  1. 194 Posts.
    lightbulb Created with Sketch. 49
    A lot of information for the market to absorb, this company just gets better IMO
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.